{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPHLPP2 is a serine/threonine phosphatase that functions as a potent tumor suppressor by directly dephosphorylating key signaling molecules such as Akt, S6K1, PKC, and even regulators like MST1 and aPKC. In doing so, it terminates pro‐survival growth factor signaling and controls translation, cell size, and apoptosis. Its catalytic activity has been biochemically characterized, revealing unique features in its active site that distinguish it from other PP2C family phosphatases. In multiple cancer types including lung, breast, and hematologic malignancies, reduced PHLPP2 expression or activity—through genetic polymorphisms, epigenetic suppression, or inhibition by oncomiRs—correlates with increased Akt phosphorylation and enhanced cell survival, proliferation, and chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA wide array of microRNAs and long noncoding RNAs have been shown to regulate PHLPP2 post‐transcriptionally, establishing complex ceRNA networks that critically modulate its protein levels. Upregulation of several oncomiRs (for example, miR‐205, miR‐141, miR‐32, miR‐372, miR‐125b, and miR‐493), as well as dysregulation of competing endogenous RNAs, results in diminished PHLPP2 expression and thereby indirectly maintains Akt activation. These regulatory axes have been described in diverse malignancies—including colorectal, bladder, prostate, breast, and multiple myeloma—where downregulation of PHLPP2 is linked to enhanced proliferation, epithelial–mesenchymal transition, invasion, and chemoresistance. Such studies illustrate that restoration of PHLPP2 levels, either by interfering with its inhibitory miRNAs or by reinforcing ceRNA interactions, may represent a promising therapeutic strategy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical role in attenuating Akt signaling, PHLPP2 is intricately involved in diverse cellular processes. It modulates responses to metabolic and proteostatic stress—for instance, by dephosphorylating pAMPK under conditions of glucose limitation—and participates in the orchestration of cell polarity, senescence, and autophagy. Growth factor studies reveal that factors like IGF‑1 can inhibit PHLPP2 activity to promote cell proliferation, while proteins such as SIK2 and E3 ubiquitin ligases (e.g., TRIM22) regulate its stability, linking its loss to enhanced tumor growth and immune escape. Moreover, crosstalk with other tumor suppressors (such as PTEN) further underscores its role in controlling invasive behavior and the balance between survival and apoptosis in cancer cells. These multifaceted actions position PHLPP2 as a central node in the regulation of oncogenic signaling and underscore its potential as a therapeutic target in cancer and metabolic diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "John Brognard, Matthew Niederst, Gloria Reyes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common polymorphism in the phosphatase PHLPP2 results in reduced regulation of Akt and protein kinase C."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M901468200"}], "href": "https://doi.org/10.1074/jbc.M901468200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19324870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19324870"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Meng Qiao, Yaqi Wang, Xiaoen Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2010.03.017"}], "href": "https://doi.org/10.1016/j.molcel.2010.03.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20513427"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20513427"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jianyu Liu, Payton D Stevens, Xin Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.05799-11"}], "href": "https://doi.org/10.1128/MCB.05799-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21986499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21986499"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Junchao Cai, Lishan Fang, Yongbo Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-0297"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-0297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23856247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23856247"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Nitin Kumar Agarwal, Xiaoping Zhu, Mihai Gagea, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.1774"}], "href": "https://doi.org/10.18632/oncotarget.1774"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24553260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24553260"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhoufang Mei, Yanchao He, Jingjing Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2014.06.020"}], "href": "https://doi.org/10.1016/j.febslet.2014.06.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24945731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24945731"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Raju V S Rajala, Yogita Kanan, Robert E Anderson "}, {"type": "b", "children": [{"type": "t", "text": "Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Exp Med Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/978-3-319-17121-0_55"}], "href": "https://doi.org/10.1007/978-3-319-17121-0_55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26427440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26427440"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Michaela Strotbek, Simone Schmid, Ismael Sánchez-González, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.30661"}], "href": "https://doi.org/10.1002/ijc.30661"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28224609"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28224609"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Chien-Feng Li, Wen-Ren Wu, Ti-Chun Chan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-0002"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-0002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28972042"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28972042"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Osamu Ishibashi, Ichiro Akagi, Yota Ogawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.05.025"}], "href": "https://doi.org/10.1016/j.bbrc.2018.05.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29738771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29738771"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Hongmei Wang, Ruixue Gu, Fanglin Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.13196"}], "href": "https://doi.org/10.1111/1759-7714.13196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31571378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31571378"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jieyu Zhou, Xuemin Yu, Juan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0119405"}], "href": "https://doi.org/10.1371/journal.pone.0119405"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25793736"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25793736"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Haishan Huang, Xiaofu Pan, Honglei Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-2829"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-2829"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25977341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25977341"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Haoming Xia, Jianting Long, Ruifen Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2015.07.037"}], "href": "https://doi.org/10.1016/j.biopha.2015.07.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26276160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26276160"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ruowen Zhang, Xun Che, Jingjie Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cheliensisin A (Chel A) induces apoptosis in human bladder cancer cells by promoting PHLPP2 protein degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11440"}], "href": "https://doi.org/10.18632/oncotarget.11440"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27556506"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27556506"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xiaopeng Xiong, Xin Li, Yang-An Wen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.740639"}], "href": "https://doi.org/10.1074/jbc.M116.740639"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27760826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27760826"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xia Cui, Qingyan Li, Yukai He "}, {"type": "b", "children": [{"type": "t", "text": "miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-016-2855-2"}], "href": "https://doi.org/10.1007/s11010-016-2855-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27822662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27822662"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yanxia Jiang, Jianghua Ding, Jing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of microRNA‑125b on multiple myeloma cell growth in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2018.6668"}], "href": "https://doi.org/10.3892/or.2018.6668"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30226579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30226579"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jun Deng, Ming Ma, Wei Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-493 Promotes Prostate Cancer Cells Proliferation by Targeting PHLPP2 and Activating Akt Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2018.180806"}], "href": "https://doi.org/10.7754/Clin.Lab.2018.180806"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30868840"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30868840"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Honglei Jin, Jiugao Ma, Jiheng Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic role of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MIR516A"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autophagy (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15548627.2020.1733262"}], "href": "https://doi.org/10.1080/15548627.2020.1733262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32116109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32116109"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jun Deng, Ming Ma, Wei Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-493 Induces Cytotoxic Autophagy in Prostate Cancer Cells through Regulation on PHLPP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Biotechnol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1389201021666200318120733"}], "href": "https://doi.org/10.2174/1389201021666200318120733"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32188381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32188381"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Hong-Kun Wu, Chang Liu, Xin-Xing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLPP2 is regulated by competing endogenous RNA network in pathogenesis of colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103246"}], "href": "https://doi.org/10.18632/aging.103246"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32633726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32633726"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jianmin Zhang, Wenzhang Zha, Changchun Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-021-10110-6"}], "href": "https://doi.org/10.1007/s10528-021-10110-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34313883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34313883"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Blaz Lupse, Karthika Annamalai, Hazem Ibrahim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2021.109490"}], "href": "https://doi.org/10.1016/j.celrep.2021.109490"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34348155"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34348155"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jicheng Tantai, Xufeng Pan, Yong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-022-04727-7"}], "href": "https://doi.org/10.1038/s41419-022-04727-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35354796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35354796"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Nannan Liu, Xinxiu Jiang, Leiming Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.67200"}], "href": "https://doi.org/10.7150/ijbs.67200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35414774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35414774"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Xing-Li Wu, Ding-You Yang, Duan-Jun Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitory effect of atorvastatin on the cell growth of cardiac myxomas via the PTEN and PHLPP2 phosphatase signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2501"}], "href": "https://doi.org/10.3892/or.2013.2501"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23715723"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23715723"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Aram Ghalali, Zhi-Wei Ye, Johan Högberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2020.110112"}], "href": "https://doi.org/10.1016/j.biopha.2020.110112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32294598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32294598"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Xiao-Man Dai, Yan-Hui Zhang, Xiao-Han Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12838"}], "href": "https://doi.org/10.1002/1878-0261.12838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33128264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33128264"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Yan Yan, Karl N Krecke, Aditi S Bapat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphatase PHLPP2 regulates the cellular response to metabolic stress through AMPK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04196-4"}], "href": "https://doi.org/10.1038/s41419-021-04196-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34608126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34608126"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Bianqin Guo, Xiaopeng Xiong, Sumati Hasani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2α phosphorylation and chemoresistance in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04251-0"}], "href": "https://doi.org/10.1038/s41419-021-04251-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34663797"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34663797"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Donghee Kang, Hyun Jung Hwang, Yurim Baek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-024-06427-w"}], "href": "https://doi.org/10.1038/s41419-024-06427-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38199981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38199981"}]}]}]}